Should we use standard survival models or the illness-death model for interval-censored data to investigate risk factors of chronic kidney disease progression? Tekijä Julie Boucquemont, Marie Metzger, Christian Combe, Bénédicte Stengel, Karen Leffondre, NephroTest Study Group

Hae kokoteksti

A 3-marker index improves the identification of iron disorders in CKD anaemia. Tekijä Lucile Mercadal, Marie Metzger, Jean Philippe Haymann, Eric Thervet, Jean-Jacques Boffa, Martin Flamant, François Vrtovsnik, Cédric Gauci, Marc Froissart, Bénédicte Stengel, NephroTest Study Group

Hae kokoteksti

Low Serum Creatine Kinase Level Predicts Mortality in Patients with a Chronic Kidney Disease. Tekijä Adrien Flahault, Marie Metzger, Jean-François Chassé, Jean-Philippe Haymann, Jean-Jacques Boffa, Martin Flamant, François Vrtovsnik, Pascal Houillier, Bénédicte Stengel, Eric Thervet, Nicolas Pallet, NephroTest study group

Hae kokoteksti

Correction to: Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study Tekijä Sandra Wagner, Marie Metzger, Martin Flamant, Pascal Houillier, Jean-Philippe Haymann, François Vrtovsnik, Eric Thervet, Jean-Jacques Boffa, Ziad A. Massy, Bénédicte Stengel, Patrick Rossignol, for the NephroTest Study group

Hae kokoteksti

Renal function can improve at any stage of chronic kidney disease. Tekijä Lise Weis, Marie Metzger, Jean-Philippe Haymann, Eric Thervet, Martin Flamant, François Vrtovsnik, Cédric Gauci, Pascal Houillier, Marc Froissart, Emmanuel Letavernier, Bénédicte Stengel, Jean-Jacques Boffa, NephroTest Study Group

Hae kokoteksti